San Antonio Breast Cancer Symposium underway

Posted: Wednesday, December 11, 2013

Health Science Center faculty member Ismail Jatoi, M.D., is a member of the San Antonio Breast Cancer Symposium Executive Committee. He also will moderate a panel discussion on “Global Trends in Breast Cancer Incidence and Mortality.” clear graphic
Health Science Center faculty member Ismail Jatoi, M.D., is a member of the San Antonio Breast Cancer Symposium Executive Committee. He also will moderate a panel discussion on “Global Trends in Breast Cancer Incidence and Mortality.”  

Email Printer Friendly Format
 

Contact: Elizabeth Allen, 210-450-2020

SAN ANTONIO (Dec. 5, 2013) — More than 7,000 physicians, researchers and advocates will participate this week in the San Antonio Breast Cancer Symposium (SABCS). The annual meeting, Dec. 10-14 at the Henry B. Gonzalez Convention Center, will highlight the latest advances in research and the treatment of breast cancer from around the world.

“We have speakers addressing novel approaches to breast cancer treatment, and also important public health issues such as screening and overdiagnosis,” said Ismail Jatoi, M.D., chief of surgical oncology at The University of Texas Health Science Center at San Antonio. He also is a member of the SABCS Executive Committee.

The SABCS is presented by the university’s Cancer Therapy & Research Center, the American Association for Cancer Research, and Baylor College of Medicine.

Faculty members to lead key panel discussions
CTRC faculty members who will participate include:

  • Rong Li, Ph.D., professor of molecular medicine at the UT Health Science Center, who will moderate a panel on “DNA Damage Response as a Target of Therapy;”

  • Dr. Jatoi, who will moderate “Global Trends in Breast Cancer Incidence and Mortality;” and

  • Richard Crownover, M.D., Ph.D., a CTRC radiation oncologist, who will moderate “Clinical Science Forum — Management of the Axilla after Neoadjuvant Systemic Therapy.”
During the week, four press conferences will highlight important news that will be revealed at the meeting. More than 1,000 papers are expected to be shared at the conference.

Rong Li, Ph.D., professor of molecular medicine, will moderate a panel on “DNA Damage Response as a Target of Therapy” at the San Antonio Breast Cancer Symposium.clear graphic
Rong Li, Ph.D., professor of molecular medicine, will moderate a panel on “DNA Damage Response as a Target of Therapy” at the San Antonio Breast Cancer Symposium. 

 

Economic impact
The estimated economic impact of the SABCS in 2012 was more than $9 million, with similar figures expected this year.

For more information
To learn more about the SABCS, including registration information and the program, please visit http://www.sabcs.org

###

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI)-designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.



HOME [HSC NEWS] | About UTHSCSA | News Releases | Mission Magazine | Grand Rounds Newly Granted | Submit News | HSC News Archive | Video Index
Photo Archive Library News | Update(Student Newsletter) | RAHC